SCHEMBL5297

SCHEMBL5297

[CH2]CC1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8923 0.92
SCHEMBL9259493 0.89 CHRM5 (0.39)
SCHEMBL867442 0.89 CHRM5 (0.39)
SCHEMBL867090 0.89 CHRM5 (0.39)
SCHEMBL2176278 0.89 CHRM5 (0.39)
SCHEMBL4945 0.89 CHRM5 (0.39)
SCHEMBL21831592 0.89 CHRM5 (0.39)
SCHEMBL21831419 0.89 CHRM5 (0.39)
SCHEMBL22027477 0.89 CHRM5 (0.39)
SCHEMBL5176 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10431 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4370206-A1 ESTERS OF 7-COOH CBD DERIVATIVES AND THEIR USE AS PREVENTION, PROPHYLAXIS OF PROGRESSION, AND/OR TREATMENT OF NEUROGENERATIVE DISEASES Receptorpharma Inc S-Corp (US) 2024-05-22 EP claimed
EP-3750894-B1 UREA-SUBSTITUTED AROMATIC RING-LINKED DIOXAZOLINE COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF BEIJING SCITECH MQ PHARMACEUTICALS LTD (CN) 2024-04-03 EP claimed
WO-2024064178-A1 HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLINE VMAT2 INHIBITORS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2024-03-28 WO claimed
WO-2024022481-A1 PHENYL-SUBSTITUTED DIHYDRONAPHTHYRIDINE COMPOUNDS, AND PREPARATION AND USE THEREOF 苏中药业集团股份有限公司 2024-02-01 WO claimed
WO-2023237097-A1 19-NOR-C3,3-DISUBSTITUTED C21-AZACYCLO-SUBSTITUTED STEROID AND METHOD FOR USING SAME 山东绿叶制药有限公司 2023-12-14 WO claimed
EP-3901147-B1 ACYLAMINO BRIDGED HETEROCYCLIC COMPOUND, AND COMPOSITION AND APPLICATION THEREOF BEIJING SCITECH MQ PHARMACEUTICALS LTD (CN) 2023-11-22 EP claimed
CN-116903480-A Method for preparing beta-enaminone based on sulfoxide and aldoxime and beta-enaminone 盐城师范学院 2023-10-20 CN claimed
CN-116640136-A Sulfonamide compound or salt acceptable as pesticide, composition and application thereof 海利尔药业集团股份有限公司 2023-08-25 CN claimed
EP-3650449-B1 FXR RECEPTOR AGONIST XUANZHU BIOPHARMACEUTICAL CO LTD (CN) 2023-08-23 EP claimed
CN-116535460-A Sulfur-containing peptidomimetic compounds, and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2023-08-04 CN claimed
US-5268391-A Cardiovascular disorders C. D. SEARLE & CO. (US) 1993-12-07 US claimed
WO-1992017469-A2 N-ARYLHETEROARYLALKYL IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-10-15 WO claimed
EP-0508393-A1 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders G.D. Searle & Co. (US) 1992-10-14 EP claimed
EP-0482804-A1 Pyrrolo[2,3-d]pyrimidines with cardiovascular activity, process for their preparation and pharmaceutical compositions containing them ZENECA LIMITED (GB) 1992-04-29 EP claimed
CN-1059336-A Anti-fungal triazole derivatives and preparation thereof and purposes SANKYO CO (JP) 1992-03-11 CN claimed
EP-0473387-A2 Anti-fungal triazole derivatives, their preparation and uses Sankyo Company Limited (JP) 1992-03-04 EP claimed
CN-1030910-A ALIPHATIC CARBOXAMIDEX ICI AMERICA INC (US) 1989-02-08 CN claimed
EP-0290145-A1 Aliphatic carboxamides ZENECA INC. (US) 1988-11-09 EP claimed
EP-0180318-A1 Amide derivatives ICI AMERICAS INC. (US) 1986-05-07 EP claimed
EP-0024960-B1 SUBSTITUTED HETEROCYCLIC PHENOXY AMINES, THEIR PREPARATION METHOD AND THEIR USE AS LOCAL ANAESTHETICS SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) 1984-12-12 EP claimed